Data / Drug companies / VistaPharm, LLC
VistaPharm, LLC: 19 products in the FDA NDC directory, labeler code 66689
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
VistaPharm, LLC (labeler code 66689) lists 19 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 15 prescription drugs, 3 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on December 13, 2024.
The request: Watch VistaPharm, LLC (FDA labeler code 66689): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66689
- Products in commercial distribution
- 19
- Packages
- 24
- Finished drugs by generic name
- 12
- Prescription products
- 15
- Over the counter products
- 3
- Controlled substance products
- Schedule II 7, Schedule IV 1
- Flagged as original packager
- 12 of 12 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- March 25, 1998
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 73.7% |
| Over the counter monograph drugs | 3 | 15.8% |
| Bulk ingredients for compounding | 1 | 5.3% |
| Other unapproved drugs | 1 | 5.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 15 | 78.9% |
| Over the counter drugs | 3 | 15.8% |
| Bulk ingredients | 1 | 5.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Methadone hydrochloride | 5 | 21 |
| Poison treatment adsorbent | 2 | 1 |
| Chlorhexidine gluconate | 1 | 34 |
| Sucralfate | 1 | 39 |
| Aripiprazole | 1 | 49 |
| Methadone | 1 | 1 |
| Mycophenolate mofetil | 1 | 37 |
| Sirolimus | 1 | 22 |
| Pyridostigmine bromide | 1 | 20 |
| Poison adsorbent | 1 | 1 |
| Digoxin | 1 | 33 |
| Metformin hydrochloride | 1 | 79 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 6 | 31.6% |
| Suspension | 4 | 21.1% |
| Tablet | 3 | 15.8% |
| Concentrate | 2 | 10.5% |
| Rinse | 1 | 5.3% |
| Powder, for suspension | 1 | 5.3% |
| Powder | 1 | 5.3% |
| Elixir | 1 | 5.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Insta-char sorbitol | 66689-115 | Suspension | Over the counter monograph drugs | December 13, 2024 |
| Insta-char aqueous | 66689-114 | Suspension | Over the counter monograph drugs | December 13, 2024 |
| Insta-char aqueous | 66689-113 | Suspension | Over the counter monograph drugs | December 13, 2024 |
| Metformin Hydrochloride | 66689-318 | Solution | Generic drugs (ANDA) | December 19, 2022 |
| Sucralfate | 66689-305 | Suspension | Generic drugs (ANDA) | March 15, 2022 |
| Chlorhexidine Gluconate | 66689-106 | Rinse | Generic drugs (ANDA) | January 24, 2022 |
| Methadone Hydrochloride | 66689-836 | Tablet | Generic drugs (ANDA) | September 11, 2020 |
| Aripiprazole | 66689-735 | Solution | Generic drugs (ANDA) | June 19, 2020 |
| Pyridostigmine Bromide | 66689-406 | Solution | Generic drugs (ANDA) | January 6, 2020 |
| Digoxin | 66689-327 | Solution | Generic drugs (ANDA) | October 4, 2019 |
| Mycophenolate Mofetil | 66689-307 | Powder, for suspension | Generic drugs (ANDA) | February 15, 2019 |
| Sirolimus | 66689-347 | Solution | Generic drugs (ANDA) | January 28, 2019 |
| Methadone Hydrochloride | 66689-820 | Tablet | Generic drugs (ANDA) | November 22, 2018 |
| Donnatal | 66689-063 | Elixir | Other unapproved drugs | October 26, 2017 |
| Methadone Hydrochloride | 66689-695 | Concentrate | Generic drugs (ANDA) | March 29, 2017 |
| Methadone Hydrochloride | 66689-711 | Solution | Generic drugs (ANDA) | August 1, 2010 |
| Methadone Hydrochloride | 66689-694 | Concentrate | Generic drugs (ANDA) | October 30, 2009 |
| Methadone hydrochloride | 66689-681 | Powder | Bulk ingredients for compounding | October 1, 2009 |
| Methadone Hydrochloride | 66689-898 | Tablet | Generic drugs (ANDA) | March 25, 1998 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.